COSMOS Pharmaceutical Corporation (TYO:3349)
6,501.00
-85.00 (-1.29%)
Sep 11, 2026, 3:30 PM JST
| Market Cap | 515.25B -27.9% |
| Revenue (ttm) | 1.10T +8.7% |
| Net Income | 32.05B +3.4% |
| EPS | 404.33 +3.4% |
| Shares Out | 79.26M |
| PE Ratio | 16.08 |
| Forward PE | 16.05 |
| Dividend | 84.00 (1.29%) |
| Ex-Dividend Date | Nov 27, 2026 |
| Volume | 378,100 |
| Open | 6,577.00 |
| Previous Close | 6,586.00 |
| Day's Range | 6,441.00 - 6,613.00 |
| 52-Week Range | 5,615.00 - 9,187.00 |
| Beta | 0.15 |
| Analysts | Buy |
| Price Target | 7,620.00 (+17.21%) |
| Earnings Date | Oct 9, 2026 |